Ru Wen

1.5k total citations
34 papers, 1.2k citations indexed

About

Ru Wen is a scholar working on Molecular Biology, Immunology and Biomaterials. According to data from OpenAlex, Ru Wen has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Immunology and 6 papers in Biomaterials. Recurrent topics in Ru Wen's work include Nanoparticle-Based Drug Delivery (6 papers), Immunotherapy and Immune Responses (6 papers) and Nanoplatforms for cancer theranostics (5 papers). Ru Wen is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Immunotherapy and Immune Responses (6 papers) and Nanoplatforms for cancer theranostics (5 papers). Ru Wen collaborates with scholars based in United States, China and Pakistan. Ru Wen's co-authors include Shanta Dhar, Jian Xu, Rakesh Pathak, Afoma C. Umeano, Bhabatosh Banik, Ammad Ahmad Farooqı, Nagesh Kolishetti, Ming Yang, Yue Du and Wenjuan Liu and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Ru Wen

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ru Wen United States	16	554	281	262	208	190	34	1.2k
Syed Mohd Faisal India	21	340 0.6×	113 0.4×	169 0.6×	129 0.6×	85 0.4×	67	1.3k
Huimin Tao China	22	589 1.1×	232 0.8×	296 1.1×	321 1.5×	56 0.3×	43	1.4k
Qibing Zhou China	23	954 1.7×	311 1.1×	188 0.7×	122 0.6×	146 0.8×	60	1.7k
Zhenzhong Zhang China	22	983 1.8×	594 2.1×	147 0.6×	101 0.5×	210 1.1×	42	1.7k
Qian Zeng China	21	498 0.9×	382 1.4×	179 0.7×	201 1.0×	107 0.6×	71	1.3k
Liqian Zhou China	27	1.1k 1.9×	423 1.5×	70 0.3×	145 0.7×	419 2.2×	69	2.0k
Cailin Chen United States	17	747 1.3×	70 0.2×	370 1.4×	173 0.8×	240 1.3×	39	1.9k
Ningning Wang China	12	232 0.4×	451 1.6×	124 0.5×	108 0.5×	237 1.2×	27	825
Ting Yan China	19	340 0.6×	111 0.4×	102 0.4×	308 1.5×	55 0.3×	75	1.0k
Shunsuke Tomita Japan	25	654 1.2×	307 1.1×	65 0.2×	85 0.4×	95 0.5×	103	1.5k

Countries citing papers authored by Ru Wen

Since Specialization

Citations

This map shows the geographic impact of Ru Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Wen more than expected).

Fields of papers citing papers by Ru Wen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ru Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Wen. The network helps show where Ru Wen may publish in the future.

Co-authorship network of co-authors of Ru Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Ru Wen. A scholar is included among the top collaborators of Ru Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ru Wen. Ru Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Dalin, Ru Wen, Fernando Jose Garcia-Marques, et al.. (2025). FTO inhibition attenuates renal fibrosis by downregulating ferroptosis activator ACSL4 and profibrotic factor TGFBI. iScience. 28(10). 113515–113515.

Wen, Ru, Gerald E. Marti, Jessica C. Stark, et al.. (2024). Abstract 7524: Targeting siglec-7/9 glyco-immune checkpoints in prostate cancer for enhanced immune responses and tumor suppression. Cancer Research. 84(6_Supplement). 7524–7524. 2 indexed citations

Wen, Ru, Jessica C. Stark, Gerald E. Marti, et al.. (2023). Siglec-7/9 are novel immune checkpoints for prostate cancer. The Journal of Immunology. 210(Supplement_1). 89.13–89.13. 1 indexed citations

Wen, Ru, Jessica C. Stark, Nicholas M. Riley, et al.. (2023). 517 Blocking Siglec-7/9-sialic acid interactions induces immune cell-mediated suppression of prostate cancer. SHILAP Revista de lepidopterología. A583–A583. 1 indexed citations

Li, Caiyun G., Erik Verschueren, Ru Wen, et al.. (2023). NUSAP1 Binds ILF2 to Modulate R-Loop Accumulation and DNA Damage in Prostate Cancer. International Journal of Molecular Sciences. 24(7). 6258–6258. 16 indexed citations

Riley, Nicholas M., Ru Wen, Carolyn R. Bertozzi, James D. Brooks, & Sharon J. Pitteri. (2022). Measuring the multifaceted roles of mucin-domain glycoproteins in cancer. Advances in cancer research. 157. 83–121. 9 indexed citations

Wen, Ru, et al.. (2022). Sialylated glycoproteins as biomarkers and drivers of progression in prostate cancer. Carbohydrate Research. 519. 108598–108598. 14 indexed citations

Wang, Juan, et al.. (2020). IoT-Praetor: Undesired Behaviors Detection for IoT Devices. IEEE Internet of Things Journal. 8(2). 927–940. 47 indexed citations

Li, Yinyin, Yi Shen, Ke Jin, et al.. (2019). The DNA Repair Nuclease MRE11A Functions as a Mitochondrial Protector and Prevents T Cell Pyroptosis and Tissue Inflammation. Cell Metabolism. 30(3). 477–492.e6. 142 indexed citations

10.

Liu, Wenjuan, Yue Du, Ru Wen, Ming Yang, & Jian Xu. (2019). Drug resistance to targeted therapeutic strategies in non-small cell lung cancer. Pharmacology & Therapeutics. 206. 107438–107438. 147 indexed citations

11.

Zhang, Weizhong, Mengzhe Wang, Wei Tang, et al.. (2018). Nanoparticle‐Laden Macrophages for Tumor‐Tropic Drug Delivery. Advanced Materials. 30(50). e1805557–e1805557. 170 indexed citations

12.

Wen, Ru, Afoma C. Umeano, Pingping Chen, & Ammad Ahmad Farooqı. (2018). Polymer-Based Drug Delivery Systems for Cancer. Critical Reviews in Therapeutic Drug Carrier Systems. 35(6). 521–553. 34 indexed citations

13.

Wang, Juan, et al.. (2018). Detecting and Mitigating Target Link-Flooding Attacks Using SDN. IEEE Transactions on Dependable and Secure Computing. 16(6). 944–956. 84 indexed citations

14.

Pathak, Rakesh, Ru Wen, Nagesh Kolishetti, & Shanta Dhar. (2017). A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer. Molecular Cancer Therapeutics. 16(4). 625–636. 55 indexed citations

15.

Banik, Bhabatosh, Ru Wen, Sean Marrache, et al.. (2017). Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution. Nanoscale. 10(1). 366–377. 12 indexed citations

16.

Wen, Ru, Xiaoyan Lv, Tao Yang, et al.. (2017). Albumin nanoreactor-templated synthesis of Gd2O3/CuS hybrid nanodots for cancer theranostics. Science China Materials. 60(6). 554–562. 19 indexed citations

17.

Wen, Ru & Afoma C. Umeano. (2017). Role of targeting nanoparticles for cancer immunotherapy and imaging. 1(3). 2 indexed citations

18.

Wen, Ru, Bhabatosh Banik, Rakesh Pathak, et al.. (2016). Nanotechnology inspired tools for mitochondrial dysfunction related diseases. Advanced Drug Delivery Reviews. 99(Pt A). 52–69. 108 indexed citations

19.

Wen, Ru, et al.. (2016). Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems. Vaccines. 4(2). 18–18. 11 indexed citations

20.

Basu, Uttara, Bhabatosh Banik, Ru Wen, Rakesh Pathak, & Shanta Dhar. (2016). The Platin-X series: activation, targeting, and delivery. Dalton Transactions. 45(33). 12992–13004. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact